Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Other Operating Expenses (2018 - 2023)

Exagen (XGN) has disclosed Other Operating Expenses for 6 consecutive years, with -$17.5 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses fell 247.88% year-over-year to -$17.5 million, compared with a TTM value of -$17.5 million through Sep 2024, down 159.66%, and an annual FY2022 reading of $29.7 million, up 44.36% over the prior year.
  • Other Operating Expenses was -$17.5 million for Q4 2023 at Exagen, down from $5.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $11.8 million in Q4 2022 and bottomed at -$17.5 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $4.3 million, with a median of $5.0 million recorded in 2019.
  • The sharpest move saw Other Operating Expenses surged 139.22% in 2022, then plummeted 247.88% in 2023.
  • Year by year, Other Operating Expenses stood at $4.6 million in 2019, then fell by 5.58% to $4.3 million in 2020, then rose by 13.93% to $4.9 million in 2021, then skyrocketed by 139.22% to $11.8 million in 2022, then tumbled by 247.88% to -$17.5 million in 2023.
  • Business Quant data shows Other Operating Expenses for XGN at -$17.5 million in Q4 2023, $5.7 million in Q3 2023, and $5.8 million in Q2 2023.